Anti-CD13 (Mouse) mAb

IP - 5 ug / 1000 uL of cell extract from 5x106 cells FCM - 5-10 ug/mL (final concentration)

CD13 is a myeloid differentiation molecule expressed on committed myeloid progenitors, granulocytes, monocytes, and leukemic cells of myeloid origin. It is also expressed on nonhematopoietic cells including fibroblasts, renal proximal tubule, and small intestine brush-border membrane. The gene for CD13 has recently been cloned the cDNA sequence shows that CD13 is the metalloprotease aminopeptidase N. Biochemical studies have shown that CD13 is a 150-kDa glycoprotein, which exists as a 130-kDa intracellular precursor form. This 130-kDa precursor molecule is post-translationally modified in the Golgi apparatus to produce the 150-kDa mature cell surface form of the molecule.

1 mg/mL

100 ug IgG in 100 ul volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained.

Human: 290 Mouse: 16790

Dendritic cells were isolated from C57BL / 6 mouse

This antibody reacts with mouse CD13 on Flow cytometry.

1 year

This antibody was purified from hybridoma (clone 123H1) supernatant using protein G agarose. This hybridoma was established by fusion of mouse myeloma cell Sp2/0-Ag14 with Wister rat lymphocyte immunized with murine DC from C57BL/6 mice.

CD13